NOVEL IMMUNO POLYUMER DEVICE FOR CD34+ CELL ISOLATION

Information

  • Research Project
  • 2646459
  • ApplicationId
    2646459
  • Core Project Number
    R43CA075781
  • Full Project Number
    1R43CA075781-01A1
  • Serial Number
    75781
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1998 - 27 years ago
  • Project End Date
    6/30/1999 - 26 years ago
  • Program Officer Name
    WU, ROY S
  • Budget Start Date
    3/1/1998 - 27 years ago
  • Budget End Date
    6/30/1999 - 26 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    2/13/1998 - 27 years ago
Organizations

NOVEL IMMUNO POLYUMER DEVICE FOR CD34+ CELL ISOLATION

DESCRIPTION: (Adapted from the applicant's abstract) The purpose of the proposed research is to develop a new stem cell selection technology based on a conducting immuno-polymer. The immunopolymer solid matrix is synthesized using a simple polymerization reaction during which stem cell-specific antibodies (anti-CD34) are entrapped. The conductive properties of this matrix could improve or solve a variety of problems associated with the current cell selection technologies. In particular, its conductivity could be exploited to monitor and computer control cell binding during the selection process, to reduce non-specific binding, and to release the selected cells. The applicant proposes to optimize the conditions of synthesis of the matrix using direct and indirect entrapment of the antibodies in the polymer. The cell binding characteristics of the immuno-polymers will be assessed using hematopoietic cell lines. Different electrochemical strategies for the release of bound cells and their effects on cell viability will be tested. The clinical applications of this technology include stem cell selection, T-cell or tumor cell depletion, and residual tumor cell enrichment for improved detection. The long term goal is to develop a cell selection device capable of directly and efficiently processing whole peripheral blood or bone marrow for transplantation. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG2
  • Study Section Name
  • Organization Name
    MORPHOGENESIS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    OLDSMAR
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    34677
  • Organization District
    UNITED STATES